A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
Clinical trial NCT04742413 · TERMINATED
Trial details
- NCT number
- NCT04742413
- Sponsor
- Angelini Farmacéutica
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-29
- Primary completion
- 2022-02-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.